G A Van Dongen - JoVE Visualize

Showing results (11-20 of 57) with videos related to

Pageof 6

Sort By:

Cancer Letters|February 1, 1990

Antitumor activity of brequinar sodium (Dup-785) against human head and neck squamous cell carcinoma xenograftsB J Braakhuis, G A van Dongen, G J Peters, et al.

Nuclear Medicine and Biology|November 6, 1998

Synthesis and evaluation of 99mTc/99Tc-MAG3-biotin conjugates for antibody pretargeting strategiesF B van Gog, G W Visser, R W Gowrising, et al.

Cancer Research|March 31, 2001

Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapyM B Vrouenraets, G W Visser, M Stigter, et al.

Archives of Otolaryngology--Head & Neck Surgery|November 1, 1991

Detection of squamous cell carcinoma xenografts in nude mice by radiolabeled monoclonal antibody E48J J Quak, M Gerretsen, A H Schrijvers, et al.

Nuclear Medicine and Biology|February 18, 1998

[186Re]-labeled mouse and chimeric monoclonal antibody 323/A3: a comparison of the efficacy in experimental human ovarian cancerE Kievit, F B van Gog, H M Schlüper, et al.

International Journal of Cancer|June 25, 1998

Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancerF B van Gog, R H Brakenhoff, M Stigter-van Walsum, et al.

Cell Biophysics|January 1, 1994

Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48M Gerretsen, G W Visser, R H Brakenhoff, et al.

International Journal of Cancer|August 14, 1999

Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinomaN L van Hal, G A van Dongen, M Stigter-van Walsum, et al.

Anticancer Research|November 1, 1989

Activity of the folate analog 10-ethyl, 10-deaza-aminopterin (10-EdAM) against human head and neck cancer xenograftsD H Brown, B J Braakhuis, G A van Dongen, et al.

Cancer Research|August 1, 1993

186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenograftsM Gerretsen, G W Visser, M van Walsum, et al.

Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:

Pageof 6

Cancer Letters|February 1, 1990

Antitumor activity of brequinar sodium (Dup-785) against human head and neck squamous cell carcinoma xenograftsB J Braakhuis, G A van Dongen, G J Peters, et al.

Nuclear Medicine and Biology|November 6, 1998

Synthesis and evaluation of 99mTc/99Tc-MAG3-biotin conjugates for antibody pretargeting strategiesF B van Gog, G W Visser, R W Gowrising, et al.

Cancer Research|March 31, 2001

Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapyM B Vrouenraets, G W Visser, M Stigter, et al.

Archives of Otolaryngology--Head & Neck Surgery|November 1, 1991

Detection of squamous cell carcinoma xenografts in nude mice by radiolabeled monoclonal antibody E48J J Quak, M Gerretsen, A H Schrijvers, et al.

Nuclear Medicine and Biology|February 18, 1998

[186Re]-labeled mouse and chimeric monoclonal antibody 323/A3: a comparison of the efficacy in experimental human ovarian cancerE Kievit, F B van Gog, H M Schlüper, et al.

International Journal of Cancer|June 25, 1998

Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancerF B van Gog, R H Brakenhoff, M Stigter-van Walsum, et al.

Cell Biophysics|January 1, 1994

Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48M Gerretsen, G W Visser, R H Brakenhoff, et al.

International Journal of Cancer|August 14, 1999

Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinomaN L van Hal, G A van Dongen, M Stigter-van Walsum, et al.

Anticancer Research|November 1, 1989

Activity of the folate analog 10-ethyl, 10-deaza-aminopterin (10-EdAM) against human head and neck cancer xenograftsD H Brown, B J Braakhuis, G A van Dongen, et al.

Cancer Research|August 1, 1993

186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenograftsM Gerretsen, G W Visser, M van Walsum, et al.

Pageof 6